These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28668868)

  • 1. Evaluation of a New Technique for iFOBT Utilising a New Sample Collection Device with Increased Buffer Stability.
    Bruns-Toepler M; Hardt P
    Anticancer Res; 2017 Jul; 37(7):3735-3740. PubMed ID: 28668868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.
    Grazzini G; Ventura L; Rubeca T; Rapi S; Cellai F; Di Dia PP; Mallardi B; Mantellini P; Zappa M; Castiglione G
    Eur J Cancer Prev; 2017 Jul; 26(4):285-291. PubMed ID: 27271031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sample storage temperature and buffer formulation on faecal immunochemical test haemoglobin measurements.
    Symonds EL; Cole SR; Bastin D; Fraser RJ; Young GP
    J Med Screen; 2017 Dec; 24(4):176-181. PubMed ID: 28073307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.
    Gies A; Cuk K; Schrotz-King P; Brenner H
    Clin Transl Gastroenterol; 2018 Jul; 9(7):168. PubMed ID: 29976921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new sampling device for faecal immunochemical testing: haemoglobin stability is still an open issue.
    Gnatta E; Zaninotto M; Epifani MG; Padoan A; Gjini R; Plebani M
    Clin Chem Lab Med; 2014 Aug; 52(8):1203-9. PubMed ID: 24516002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer.
    Fraser CG; Mathew CM; McKay K; Carey FA; Steele RJ
    Gut; 2008 Sep; 57(9):1256-60. PubMed ID: 18467371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of an artificial stool usable for the surveillance of faecal haemoglobin testing.
    Miike A; Ogawa Z; Sakurabayashi I
    Ann Clin Biochem; 2018 May; 55(3):394-399. PubMed ID: 28856900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A double immunochemical method for detecting faecal haemoglobin and albumin in rectal screening].
    Tarpay A; Szabadosné Németh M; Orosz E; Kásler M; Burai M; Pap A; Ottó S
    Magy Onkol; 2011 Nov; 55(4):268-73. PubMed ID: 22128309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
    Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
    Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
    Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
    Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum.
    Rutka M; Bor R; Bálint A; Fábián A; Milassin Á; Nagy F; Szepes Z; Szűcs M; Tiszlavicz L; Farkas K; Molnár T
    Mediators Inflamm; 2016; 2016():2492081. PubMed ID: 27413251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin.
    Young GP; St John DJ; Cole SR; Bielecki BE; Pizzey C; Sinatra MA; Polglase AL; Cadd B; Morcom J
    J Med Screen; 2003; 10(3):123-8. PubMed ID: 14561263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer.
    Huang Y; Ge W; London V; Li Q; Cai S; Zhang S; Zheng S
    Clin Chem Lab Med; 2013 Nov; 51(11):2173-80. PubMed ID: 24145058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colorectal cancer screening.
    Dancourt V; Hamza S; Manfredi S; Drouillard A; Bidan JM; Faivre J; Lepage C
    Eur J Cancer Prev; 2016 Mar; 25(2):109-14. PubMed ID: 25830897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
    Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low faecal haemoglobin concentration potentially rules out significant colorectal disease.
    McDonald PJ; Digby J; Innes C; Strachan JA; Carey FA; Steele RJ; Fraser CG
    Colorectal Dis; 2013 Mar; 15(3):e151-9. PubMed ID: 23199241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colorectal cancer screening based on quantitative determining of fecal hemoglobin and transferrin].
    Filimonov AV; Kotlyarov EV; Bilan EV
    Vopr Onkol; 2015; 61(6):994-7. PubMed ID: 26995994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.